Canada Life’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Canada Life’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-21,040	Closed	-$263K	–	2534
2016 Q4	$263K	Hold	21,040	–	–	﹤0.01%	1837
2016 Q3	$287K	Hold	21,040	–	–	﹤0.01%	1819
2016 Q2	$155K	Hold	21,040	–	–	﹤0.01%	1948
2016 Q1	$134K	Hold	21,040	–	–	﹤0.01%	1578
2015 Q4	$131K	Hold	21,040	–	–	﹤0.01%	1568
2015 Q3	$123K	Hold	21,040	–	–	﹤0.01%	1558
2015 Q2	$173K	Buy	21,040 +10,500	+100%	+$92.9K	﹤0.01%	1457
2015 Q1	$87K	Hold	10,540	–	–	﹤0.01%	1881
2014 Q4	$72K	Hold	10,540	–	–	﹤0.01%	1949
2014 Q3	$57K	Hold	10,540	–	–	﹤0.01%	1989
2014 Q2	$67K	Hold	10,540	–	–	﹤0.01%	1808
2014 Q1	$85K	Hold	10,540	–	–	﹤0.01%	1501
2013 Q4	$72K	Buy	+10,540	New	+$56.9K	﹤0.01%	1573

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Canada Life's ARIA Position: Q1 2017 in Review

Canada Life sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 21,040 shares — an estimated $263K sold.

Canada Life first reported a position in ARIA in Q4 2013 and held it in 13 quarters. The position peaked at $287K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Canada Life reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Canada Life sold 21,040 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $263K.
Canada Life first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 13 quarters.
Canada Life's Ariad Pharmaceuticals Inc position peaked at $287K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Canada Life's 13F filing for Q1 2017, filed 1 May 2017.